Symbol | Market cap | Price | Change % | Volume | Rel Volume | P/E | EPS dil TTM | EPS dil growth TTM YoY | Div yield % TTM | Sector | Analyst Rating |
---|---|---|---|---|---|---|---|---|---|---|---|
NOVO_BNOVO NORDISK B A/S | 4.363 T DKK | 984.0 DKK | +1.10% | 2.458 M | 0.95 | 49.42 | 19.91 DKK | +47.53% | 0.96% | Health Technology | Buy |
GMABGENMAB A/S | 127.061 B DKK | 1930.0 DKK | −0.54% | 143.556 K | 0.65 | 23.31 | 82.78 DKK | +3.37% | 0.00% | Health Technology | Buy |
ZEALZEALAND PHARMA A/S | 40.449 B DKK | 650.0 DKK | −0.15% | 547.373 K | 1.67 | — | −12.52 DKK | +46.15% | 0.00% | Health Technology | Strong buy |
HLUN_AH. LUNDBECK A/S A | 29.325 B DKK | 32.40 DKK | −0.46% | 24.994 K | 0.23 | 13.31 | 2.43 DKK | +1.46% | 2.16% | Health Technology | — |
HLUN_BH. LUNDBECK A/S B | 29.325 B DKK | 36.92 DKK | +0.33% | 371.465 K | 0.88 | 15.17 | 2.43 DKK | +1.46% | 1.90% | Health Technology | Neutral |
BAVABAVARIAN NORDIC A/S | 14.1 B DKK | 180.75 DKK | −0.85% | 159.455 K | 0.46 | 14.10 | 12.82 DKK | +241.38% | 0.00% | Health Technology | Buy |
ORPHAORPHAZYME A/S | 33.726 M DKK | 955.1 DKK | −4.45% | 8 | 0.31 | — | −737.65 DKK | +95.89% | 0.00% | Health Technology | — |